LifeMD, Inc. (LFMDP)
USD 22.12
(1.28%)
USD 22.12
(1.28%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 152.54 Million USD | 28.15% |
| 2022 | 119.03 Million USD | 28.16% |
| 2021 | 92.87 Million USD | 149.04% |
| 2020 | 37.29 Million USD | 199.1% |
| 2019 | 12.46 Million USD | 49.79% |
| 2018 | 8.32 Million USD | 64.68% |
| 2017 | 5.05 Million USD | -3.51% |
| 2016 | 5.23 Million USD | 329.79% |
| 2015 | 1.21 Million USD | 70.67% |
| 2014 | 714.15 Thousand USD | -11.65% |
| 2013 | 808.36 Thousand USD | 19.97% |
| 2012 | 673.77 Thousand USD | -9.42% |
| 2011 | 743.82 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 44.14 Million USD | -1.6% |
| 2024 Q2 | 50.66 Million USD | 14.76% |
| 2023 Q1 | 33.12 Million USD | 17.8% |
| 2023 Q3 | 38.61 Million USD | 7.42% |
| 2023 Q4 | 44.85 Million USD | 16.18% |
| 2023 FY | 152.54 Million USD | 28.15% |
| 2023 Q2 | 35.94 Million USD | 8.51% |
| 2022 FY | 119.03 Million USD | 28.16% |
| 2022 Q1 | 29.04 Million USD | 5.93% |
| 2022 Q2 | 30.45 Million USD | 4.87% |
| 2022 Q3 | 31.41 Million USD | 3.13% |
| 2022 Q4 | 28.11 Million USD | -10.48% |
| 2021 Q4 | 27.41 Million USD | 9.9% |
| 2021 Q1 | 18.19 Million USD | 41.14% |
| 2021 Q2 | 22.31 Million USD | 22.61% |
| 2021 Q3 | 24.94 Million USD | 11.8% |
| 2021 FY | 92.87 Million USD | 149.04% |
| 2020 Q4 | 12.89 Million USD | 17.15% |
| 2020 Q1 | 4.3 Million USD | 9.14% |
| 2020 Q2 | 9.08 Million USD | 111.15% |
| 2020 Q3 | 11 Million USD | 21.08% |
| 2020 FY | 37.29 Million USD | 199.1% |
| 2019 Q3 | 3.12 Million USD | 15.87% |
| 2019 Q4 | 3.94 Million USD | 26.15% |
| 2019 FY | 12.46 Million USD | 49.79% |
| 2019 Q2 | 2.69 Million USD | -0.02% |
| 2019 Q1 | 2.69 Million USD | 23.55% |
| 2018 Q1 | 1.6 Million USD | 9.2% |
| 2018 FY | 8.32 Million USD | 64.68% |
| 2018 Q4 | 2.18 Million USD | -12.46% |
| 2018 Q3 | 2.49 Million USD | 22.47% |
| 2018 Q2 | 2.03 Million USD | 26.84% |
| 2017 Q1 | 424.46 Thousand USD | -56.95% |
| 2017 Q2 | 1.1 Million USD | 160.9% |
| 2017 Q4 | 1.47 Million USD | -28.3% |
| 2017 FY | 5.05 Million USD | -3.51% |
| 2017 Q3 | 2.05 Million USD | 85.27% |
| 2016 Q1 | 1.64 Million USD | 339.54% |
| 2016 FY | 5.23 Million USD | 329.79% |
| 2016 Q3 | 1.38 Million USD | 12.81% |
| 2016 Q2 | 1.22 Million USD | -25.21% |
| 2016 Q4 | 985.9 Thousand USD | -28.79% |
| 2015 FY | 1.21 Million USD | 70.67% |
| 2015 Q4 | 373.34 Thousand USD | 33.39% |
| 2015 Q3 | 279.88 Thousand USD | 0.91% |
| 2015 Q2 | 277.35 Thousand USD | -3.79% |
| 2015 Q1 | 288.27 Thousand USD | 80.57% |
| 2014 Q1 | 192.42 Thousand USD | 19.87% |
| 2014 Q4 | 159.64 Thousand USD | -3.52% |
| 2014 Q3 | 165.46 Thousand USD | -15.84% |
| 2014 Q2 | 196.61 Thousand USD | 2.17% |
| 2014 FY | 714.15 Thousand USD | -11.65% |
| 2013 Q3 | 94.67 Thousand USD | -70.68% |
| 2013 Q2 | 322.9 Thousand USD | 40.24% |
| 2013 Q1 | 230.25 Thousand USD | 99.25% |
| 2013 Q4 | 160.52 Thousand USD | 69.55% |
| 2013 FY | 808.36 Thousand USD | 19.97% |
| 2012 FY | 673.77 Thousand USD | -9.42% |
| 2012 Q1 | 178.53 Thousand USD | 0.0% |
| 2012 Q2 | 227.56 Thousand USD | 27.46% |
| 2012 Q3 | 152.11 Thousand USD | -33.16% |
| 2012 Q4 | 115.56 Thousand USD | -24.03% |
| 2011 FY | 743.82 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | - USD | -Infinity% |
| BIMI International Medical Inc. | 11.83 Million USD | -1189.452% |
| China Jo-Jo Drugstores, Inc. | 154.54 Million USD | 1.29% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 130.19 Million USD | -17.17% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 130.19 Million USD | -17.17% |
| Leafly Holdings, Inc. | 42.25 Million USD | -261.041% |
| Leafly Holdings, Inc. | 42.25 Million USD | -261.041% |
| LifeMD, Inc. | 152.54 Million USD | 0.0% |
| TRxADE HEALTH, Inc. | 8.27 Million USD | -1744.089% |
| PetMed Express, Inc. | 281.06 Million USD | 45.725% |
| Walgreens Boots Alliance, Inc. | 147.65 Billion USD | 99.897% |